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Summary 
Punctuated antigenic change is believed to be a key element in the 
evolution of influenza A; clusters of antigenically similar strains 
predominate world-wide for several years until an antigenically distant 
mutant emerges and instigates a selective sweep. It is thought that a 
region of East-Southeast Asia with year-round transmission acts as a 
source of antigenic diversity for influenza A and seasonal epidemics in 
temperate regions make little contribution to antigenic evolution. We 
use a mathematical model to examine how different transmission 
regimes affect the evolutionary dynamics of influenza over the lifespan 
of an antigenic cluster. Our model indicates that, in non-seasonal 
regions, mutants that cause significant outbreaks appear before the 
peak of the wildtype epidemic. A relatively large proportion of these 
mutants spread globally. In seasonal regions, mutants that cause 
significant local outbreaks appear each year before the seasonal peak 
of the wildtype epidemic, but only a small proportion spread globally. 
The potential for global spread is strongly influenced by the intensity of 
non-seasonal circulation and coupling between non-seasonal and 
seasonal regions. Results are similar if mutations are neutral, or confer 
a weak to moderate antigenic advantage. However, there is a 
threshold antigenic advantage, depending on the non-seasonal 
transmission intensity, beyond which mutants can escape herd 
immunity in the non-seasonal region and there is a global explosion in 
diversity. We conclude that non-seasonal transmission regions are 
fundamental to the generation and maintenance of influenza diversity 
due to their epidemiology. More extensive sampling of viral diversity in 
such regions could facilitate earlier identification of antigenically novel 
strains and extend the critical window for vaccine development. 
1 
Introduction 
Influenza A viruses are responsible for regular epidemics, and 
occasional pandemics, throughout the world (1). From 1968 until the 
recent emergence of a new pandemic influenza A (H1N1) virus the 
majority of infections have been caused by the H3N2 subtype (1-3). 
Rapid but low fidelity replication facilitates genetic diversification in the 
viral population. Mutations affecting the virus surface proteins may 
result in less efficient recognition by protective antibodies and 
necessitate regular updates of the influenza vaccine (4-6). Genetic 
changes accumulate continuously in the influenza genome. Antigenic 
change, however, appears to take the form of punctuated jumps 
interspersed with small scale drift (7-9); clusters of antigenically 
similar strains persist for several years until an antigenically distant 
strain emerges to found a replacement cluster. Modeling studies 
suggest that the punctuated aspect of the evolutionary pattern can be 
explained by broad short-term cross-immunity (10-11) or antigenic 
landscapes composed of ‘neutral’ networks (12). In the latter case, 
following the founding of a new antigenic cluster, antigenically neutral 
or nearly neutral drift mutations accumulate, exploring the sequence 
space until an antigenically distant mutant emerges to seed a new 
cluster that replaces the existing one. 
In temperate regions influenza incidence is seasonal. There is a 
pronounced epidemic peak in winter and infections are rarely observed 
in summer (13-14). Influenza incidence is less variable in tropical and 
subtropical regions and, over the course of a whole year, the total 
number of infections is believed to be similar in all regions (15). 
Phylogenetic analysis has suggested that temperate epidemics are 
probably reseeded every year from an external source (2, 16-17) and 
revealed little evidence for positive selection over the course of 
temperate region influenza seasons (17). Early phylogenetic studies 
suggested that many new antigenic variants of influenza emerge in 
China and neighbouring countries (18-19). A more recent study 
suggested that seasonal influenza epidemics are started each year by 
viruses imported from a region of East-Southeast Asia, and implied 
that the majority of antigenic evolution occurs in this region (20). This 
area includes countries with tropical and subtropical climates; local 
oscillations in incidence are relatively small and poorly synchronized, 
resulting in year-round transmission on a regional scale. 
Here we use a mathematical model to examine how seasonal and non­
seasonal transmission regimes, and their global interplay, influence the 
evolution of influenza over the three to five year periods between large 
punctuated antigenic jumps, which we do not model. A mutant with a 
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large antigenic advantage relative to circulating strains will experience 
a relatively large susceptible population. As such, the system is not at 
equilibrium and epidemic infection dynamics are expected even if the 
underlying transmission rate is seasonally invariant. Within this 
transient epidemiological context we focus on the impact of 
antigenically neutral and nearly neutral mutations but, where pertinent, 
also explore the implications of more significant antigenic changes. We 
start with simple intuitive models, and gradually build up layers of 
insight to arrive at a fuller understanding of the various mechanisms at 
work, and how they fit together in more complex models.  
 
Mathematical model 
Our model is based on a conventional extension of the standard SIR 
framework to multiple co-circulating strains with immune cross-
reaction (7, 10, 12, 21-33). The global population is divided into three 
distinct regions (Fig. 1), each of population size N. Two regions are 
characterized by transmission and non-transmission seasons that each 
last six months and do not overlap. The underlying probability of 
transmission intensity  is zero in the non-transmission season and 
positive in the transmission season, changing sinusoidally with a 
maximum of (1 + ) at the midpoint of the season. In the third region 
transmission is constant year-round. In each region individuals make 
transmissible contact with other individuals in the same region at rate 
, and with individuals in other regions at rate ZW where ZW is much 
less than 1. The seasonal transmission regions are directly coupled to 
each other by SS, and coupled with the non-seasonal transmission 
region by YS. Infected individuals recover at rate . Natural mortality 
occurs at rate , and an equal birthrate ensures the population size 
remains constant.  
 
The interaction of multiple strains is modeled using a history-based 
approach. Hosts are classified according to the virus strains with which 
they are currently infected, and those with which they have been 
previously infected. Virus strains are defined by a fifty element binary 
genotype. Forty elements are phenotypically neutral, ten determine 
antigenic similarity. Immunity reduces susceptibility. Hosts who have 
recovered from an infection acquire permanent complete immunity to 
the infecting strain and partial immunity to other strains. There is no 
temporary immunity. The antigenic Hamming distance between two 
strains h is the number of antigenic bitstring locations at which they 
are different. Cross-immunity g is linearly related to the Hamming 
distance g(h) = min{h, 1} where 0 <  < 1 is the antigenic advantage 
associated with a single point mutation. Nearly neutral mutations are 
represented by values of close to 0. If a host has experienced more 
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than one previous infection, the immune response is determined by 
the previous strain most closely related to the challenging strain.  
 
The start point of our time-frame is the emergence of a mutant, 
termed the wildtype, that is antigenically distant from previously 
circulating strains. We approximate this circumstance with the 
assumption that the entire population is susceptible. Consequently, the 
epidemiological dynamics are transient in all regions. In the non-
seasonal transmission region there is a single wildtype epidemic lasting 
several years (Fig S1). In the seasonal transmission regions, there are 
sequences of epidemics over several years.  The epidemics end due to 
stochastic fade out when the susceptible population is sufficiently 
depleted. Generally, the time until fade-out is longer if the 
transmission intensities are lower. The model is iterated as a discrete 
population, continuous time Markov process using the Gillespie 
algorithm (34). Full details can be found in the Supplementary 
Information.  
 
Results 
Decoupled regions, wildtype and up to one mutant 
Here we consider individual, decoupled, regions to assess the effects of 
seasonal and non-seasonal transmission on epidemic potential. 
Classically, the epidemic potential of a pathogen is expressed by the 
basic reproductive number R0, the number of secondary infections 
resulting from a single infected individual in an otherwise naive 
population. If transmission is non-seasonal, R0 =  (35-36). If 
transmission is seasonal, the expected number of secondary infections 
depends on the time at which the infected individual is introduced, and 
is termed the effective reproductive number Re(t) = t For basic 
models, branching process arguments give expressions for the 
probability that a single infected individual causes a significant 
outbreak (37-39). In order to compute corresponding probabilities 
using our model we define an ‘epidemic’ to be at least 50 simultaneous 
infections.  When transmission is non-seasonal, the time of the initial 
infection does not affect the probability of an epidemic. When 
transmission is seasonal, even though Re(t) > 1 and each infection is 
expected to lead to more than one secondary infection throughout the 
transmission season, infections introduced in the latter half of the 
season rarely lead to a significant outbreaks (Fig. S2). Immediately 
after introduction the number of infections increases slowly. A 
declining transmission rate exacerbates this effect and the end of the 
season curtails transmission before the epidemic gains momentum.  
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As the wildtype strain circulates immunity accumulates in the host 
population. The epidemic potential of a second, mutant, strain depends 
on the size of the immune classes in the population and their 
susceptibility to re-infection.  Mutant epidemics, defined as at least 50 
simultaneous infections, will usually manifest as outbreaks within the 
wildtype epidemic. As the wildtype epidemic progresses, the 
probability that a single neutral or nearly neutral mutant strain will 
cause an epidemic decreases (Fig. 2). If transmission is non-seasonal, 
this decrease becomes rapid as the wildtype epidemic approaches its 
peak. If transmission is seasonal the decrease is less pronounced 
because wildtype epidemics are curtailed by the end of each season, 
before the susceptible population is exhausted, and immunity 
accumulates more slowly. Furthermore, the mid-season peak in the 
transmission rate may allow an infected individual to infect several 
others, even when there is extensive immunity in the population. 
Mutants in seasonal regions are most likely to be successful if they are 
introduced around the second month of the transmission period. The 
success rate of earlier mutants is reduced by the low transmission rate. 
Later mutants are compromised by the low transmission rate, 
accumulating host immunity and the brevity of the remaining 
transmission season. Relatively large antigenic advantages – for our 
parameter set re-infection probabilities of up to 0.6 - have only a weak 
impact on the probability that a mutant will be successful. However, 
when the re-infection probability exceeds around 0.6, mutant epidemic 
probabilities increase rapidly and become almost independent of the 
wildtype dynamics (Fig. S2).  
 
Coupled regions, wildtype and one mutant 
Here we assess the effects of coupling on mutant epidemics, 
persistence and global spread using the model with two seasonal 
transmission regions and one non-seasonal transmission region. We 
consider a wildtype, introduced at time t = 0, and a single mutant strain 
with a probability  of re-infecting individuals immune to the wildtype. 
Coupling affects the wildtype epidemic behavior in all regions. Stronger 
direct coupling between the seasonal regions increases the magnitude 
of the seasonal epidemics (Fig. S3). Stronger coupling between the 
seasonal and non-seasonal regions increases the magnitude of 
epidemics in all regions (Fig. S4). The mutant strain is introduced into 
this epidemiological context at a random time. We define a mutant 
epidemic in a region to be at least 50 simultaneous infections.  
 
A nearly neutral mutant introduced to the seasonal region is more 
likely to cause an epidemic in that region than in other regions (Fig. 
3a). If it does escape from the seasonal region, it usually becomes 
 6
established in all regions, which we term cosmopolitan. Mutants are 
only likely to spread to other regions if they are introduced in the first 
year of the wildtype epidemic (Figs. 3b-d), near the start of the 
transmission season (Fig. S5). In the second year, the probability that 
a mutant becomes established locally is 20-40% lower than the first 
year, and the probability that it spreads elsewhere is 80-90% lower. 
Stronger coupling between seasonal and non-seasonal transmission 
regions increases the probability that the seasonal region mutant 
becomes cosmopolitan. A nearly neutral mutant introduced to the non-
seasonal region has a lower probability of becoming established locally 
than a mutant in the seasonal region. However, a large proportion of 
locally successful mutants become cosmopolitan (Fig. 3e). Mutants are 
most likely to spread to other regions if they are introduced some time 
during the first year of the wildtype epidemic (Figs. 3f-h, S5). In the 
second year, the probability that a mutant becomes established locally 
is 60% lower, and the probability that it spreads elsewhere is 95% 
lower. Stronger coupling between the seasonal and non-seasonal 
transmission regions has little impact unless close to zero, in which 
case it increases the probability that non-seasonal mutants become 
cosmopolitan. 
 
Regardless of the region into which the mutant is introduced the direct 
coupling between seasonal regions has little impact (Fig. S6). Results 
are similar if the mutant is neutral, has a small or intermediate 
antigenic advantage (Figs. S5 – S9). However, the overall probability 
that a non-seasonal mutant becomes cosmopolitan begins to increase 
rapidly when the re-infection probability exceeds approximately 0.5 
(Fig. S10). This increase is driven by mutants introduced in the second 
and third years having a much higher chance of becoming established.  
 
Coupled regions, multiple spontaneous mutants  
Here we extend the coupled model to allow mutant strains to emerge 
spontaneously. Initially the wildtype strain is introduced and an 
epidemic commences. Each element of the dominant viral genotype 
associated with each infected individual has a small probability of 
switching as long as that individual is infected.  Each difference in the 
antigenically relevant section of the genotypes confers a re-infection 
probability of up to a maximum of 1.  
 
When the antigenic advantage of each mutation is nil ( = 0), weak ( 
= 0.1) or intermediate ( = 0.3), mutants are more likely to be 
successful, i.e. cause significant outbreaks, in the region where they 
originate than elsewhere (Figs. 4a,b, S11). In the seasonal region, the 
majority of all mutants appear in the first year of the wildtype 
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epidemic, when the number of wildtype infections is highest. Most of 
these mutants appear in the second half of the transmission season. 
Nevertheless, a large proportion of all mutants that cause significant 
outbreaks appear in the first half of the transmission season (Fig. S16, 
S17). In the non-seasonal region, the majority of all mutants appear 
almost two years into the wildtype epidemic, again when the number 
of wildtype infections is highest, but the majority of successful mutants 
appear six months before this.  
 
In general, mutants arising in the non-seasonal region are more likely 
to spread globally than mutants arising in seasonal regions. Stronger 
coupling between non-seasonal and seasonal regions increases the 
probability that mutants will spread globally, weakly for seasonal 
mutants, more strongly for non-seasonal mutants (Fig. 4a,b). If 
coupling is stronger, the majority of successful non-seasonal mutants 
still appear before the majority of all mutants, although everything 
happens earlier.  
 
Stronger coupling causes the majority of all non-seasonal mutants to 
appear earlier, but still after the majority of successful mutants. A 
larger proportion of seasonal mutants appear in the second year, but 
again after a large proportion of the successful mutants in that year 
(Fig. S17).  Stronger coupling between seasonal regions has little 
impact (Figs. S12, S17). The amplitude of the transmission rate 
fluctuations determines, to some extent, whether or not seasonal 
epidemics occur at all. Consequently, low amplitude fluctuations can 
severely limit the epidemic potential or wildtype and mutant strains 
alike. Away from this region, however, the amplitude of seasonal 
fluctuations has little clear impact on the epidemic potential of mutant 
strains (Figs. S13, S17).  
 
If mutation is neutral or weakly advantageous, higher non-seasonal 
transmission intensity leads to weak increases in the probabilities that 
seasonal or non-seasonal mutants will be successful in the non-
seasonal region (Figs. S14, S18). If mutation has an intermediate 
advantage, the probability of a significant outbreak increases rapidly 
when non-seasonal transmission intensity exceeds a certain threshold, 
in this case R0 = 1.3, and there is an explosion in diversity. Similarly, if 
R0 is fixed, greater antigenic advantages conferred by each mutation 
have little impact until the re-infection probability reaches a certain 
threshold, in this case around 0.5 (Fig. 4c.d). Then the probability that 
non-seasonal mutants cause significant outbreaks locally, and in 
seasonal regions, begins to increase rapidly until, at  = 0.7, there is 
an explosion in diversity. Weak to intermediate antigenic advantages 
have little impact on the phase lag between the appearance of the 
majority of successful mutants and the majority of all mutants (Fig. 
S18). A large antigenic advantage, however, leads the majority of 
successful non-seasonal mutants to appear in phase with the majority 
of all mutants. 
Viral diversity, expressed transiently in terms of the number of extant 
genotypes, and cumulatively in terms of the total number of genotypes 
appearing over several years, is generally similar if the antigenic 
advantage of mutation is nil, weak or intermediate. Transient diversity 
is proportional to the number of infected individuals (Fig. S19). 
Cumulative diversity depends mainly on transmission intensity, again 
an indicator for the number of infected individuals, and most mutants 
arise directly from the wildtype (Fig. S20). However, when the re­
infection probability associated with each mutation exceeds a certain 
threshold, which depends on the intensity of non-seasonal 
transmission, diversity begins to increase rapidly in the non-seasonal 
region. If the re-infection probability increases further, there is an 
explosion in diversity. 
Discussion 
We have used a mathematical model to investigate how seasonal and 
non-seasonal transmission paradigms influence the evolution of 
influenza A between the relatively large, punctuated, antigenic jumps. 
A study based on a deterministic model of a single epidemic with non­
seasonal transmission found that longer epidemics facilitate greater 
antigenic drift, and that the majority of this drift occurs before the 
epidemic peaks (24). In the context of a spatially structured host 
population with multiple coupled transmission paradigms and viral 
evolution in a high dimensional antigenic space, we have shown that 
the epidemiology of regions with non-seasonal transmission makes 
them central to viral evolution, while the role of seasonal regions is 
limited by their epidemiology. In particular: 
(i) In non-seasonal regions, mutant strains with the highest chance of 
causing significant local outbreaks emerge before the wildtype 
epidemic peaks – earlier than the majority of mutants. A large 
proportion of these mutants become cosmopolitan. After the epidemic 
peak, the effective reproductive number of mutants is low, even if they 
have a moderate antigenic advantage, and they do not benefit from 
the epidemic momentum enjoyed by the wildtype. 
(ii) In seasonal regions, the mutant strains with the highest chance of 
causing significant local outbreaks, throughout the global wildtype 
epidemic, emerge in the first half of the transmission season - earlier 
than the majority of mutants. However, these mutants are unlikely to 
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spread globally unless they emerge at the start of the first season of 
the wildtype epidemic. The seasonal fluctuation in transmission 
intensity introduces a strong founder effect and allows mutants to 
temporarily escape the effects of herd immunity. However, mutants 
must appear early for an outbreak to build momentum before the 
transmission season ends. 
(iii) The extent of migration between non-seasonal and seasonal 
transmission regions strongly influences whether mutant strains 
become cosmopolitan, wherever they first arise. Throughout the 
transmission periods there is continuous potential migration between 
non-seasonal and seasonal regions. Strains arising in seasonal regions 
can persist by migrating to non-seasonal regions. Strains circulating 
year-round have multiple opportunities to migrate to seasonal regions 
at the beginning of a transmission period when it is easier to found an 
epidemic. 
(iv) Direct migration between out of phase seasonal transmission 
regions has little impact on the global spread of mutant strains. The 
overlap is brief, the epidemic in the donor region is winding down and 
colonization of the destination region is difficult because the 
transmission rate is low at the beginning of the season. The 
accumulation of host immunity accentuates this effect as it effectively 
shortens the transmission seasons, reducing the overlap. 
(v) The probability that mutants cause significant outbreaks is similar 
if all mutations are antigenically neutral, or some mutations confer a 
weak to moderate antigenic advantage. However, after the antigenic 
advantage conferred by mutation exceeds a certain threshold, there is 
a rapid increase in the probability of significant outbreaks in the non­
seasonal region and an explosion in the global viral diversity. This 
threshold depends on the intensity of non-seasonal transmission. In 
the non-seasonal region, most mutants appear around the epidemic 
peak, but by this time there is extensive immunity in the population. 
Therefore, the epidemic potential of the majority of mutants only 
increases significantly when their antigenic advantage allows them to 
escape the herd immunity at, and beyond, this point of the wildtype 
epidemic. 
Our insights are based on numerical solutions of stochastic, discrete 
population, continuous time models. In order to maintain 
computational efficiency we used relatively small population sizes and 
a coarse spatial structure with clearly defined seasonal and non­
seasonal transmission paradigms. We expect larger, more structured 
populations to lead to non-seasonal epidemics that build more 
gradually and last longer as immunity accumulates more slowly. This 
change of intensity may make it easier for multiple strains to co­
9 
circulate. Allowing low-level transmission throughout seasonal ‘non­
transmission’ periods may enhance the persistence of mutants in these 
regions. Additional regions with less clearly defined transmission 
paradigms may lead to increased migration between the well-defined 
seasonal and non-seasonal transmission regions. Weak localised 
seasonality in subregions of ‘non-seasonal’ regions may introduce 
some disruptive noise into the pattern of circulation and evolution. 
Assessing the impact of these factors is an important area for future 
research. The results presented here provide a baseline for comparison. 
Given that our results are consistent across a range of model 
complexities we do not, however, expect them to be substantially 
modified by any of these additional factors. 
Our analysis indicates that one key characteristic of a source region is 
consistency of transmission. Factors often considered to enhance the 
regularity and duration of transmission include large host populations 
and a regional population structure composed of well-connected but 
semi-autonomous patches (40-42). A second key characteristic of a 
source region is strong connectivity to seasonal regions. A pronounced 
founder effect means that a strain introduced at the start of the 
seasonal transmission period is likely to dominate for the whole winter. 
Even antigenically advantaged mutants must be introduced in the first 
half the of the transmission period if they are to cause a significant 
outbreak. Regions with year-round transmission and strong global 
connectivity are much more likely to supply these founders. Genetic 
surveillance has suggested that most seasonal epidemics are started 
by viral seeds from East-Southeast Asia (2, 18-20). Asynchronous sub­
regional epidemic patterns, high population density and widespread 
exchange with temperate region populations suggest that 
epidemiological conditions in this region are ideal for a source of 
antigenic novelty. As more epidemiological data become available from 
the tropics and subtropics it should be possible to identify further 
potential source regions. 
Our analysis also indicates that antigenically novel mutants that rise to 
global predominance are likely to appear in a region with a stable 
transmission pattern, from lineages established some time before the 
peak of the epidemic associated with the currently predominant 
antigenic cluster. Extensive sampling of viral genetic diversity in 
regions identified as likely evolutionary sources will be required to 
identify such strains. Real-time phylogenetic monitoring, in 
combination with analysis of antigenic and epidemiological data, may 
then aid the earlier detection of novel antigenic variants. Improving 
our understanding of the epidemiology of influenza throughout tropical 
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and subtropical regions, and integrating this information with 
evolutionary analysis, is thus essential to improve predictions of the 
antigenic cluster transitions that are critical for vaccine efficacy. 
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Figures 
 
Fig. 1: Schematic model diagram. The global population is divided into 
three regions. Transmission is seasonal in two regions, year-round in 
the third.  Each population consists of susceptible (S), infected (I) and 
recovered (R) individuals. Black lines indicate the flow between these 
states. Grey lines indicate transmission interaction.  
 
 
Fig. 2: Probabilities, as a function of introduction time, that a 
significant outbreak (at least 50 simultaneous infections) results from 
the introduction of one individual infected with a mutant strain into a 
population experiencing a wildtype epidemic. a – non-seasonal 
transmission, b - seasonal transmission. Circles, black: mutant strain 
has no antigenic advantage ( = 0). Triangles, mid-grey: mutant can 
re-infect individuals immune to wildtype with probability  = 0.1. 
Squares, pale grey:   = 0.3. Pluses:  = 0.7.  Each set of points is 
based on 10000 independent trials with random introduction times. 
Initially all hosts susceptible except for 10 individuals with wildtype 
infections. Parameters values as in Table S1.   
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Fig. 3: Probabilities, as a function of coupling between seasonal and 
non-seasonal regions, that a significant outbreak results from the 
introduction of one individual infected with a mutant strain into a 
population experiencing a wildtype epidemic. Top row: mutant 
introduced in seasonal region #1. Bottom row: mutant introduced in 
non-seasonal region. a, e. Total probability over all introduction times 
in the first four years of the wildtype epidemic. b, f. Probability if the 
mutant strain is introduced in year 1. c, d, g, h. Probability if the 
mutant is introduced in year 2 or 3, expressed as the percentage 
change relative to year 1. Circles: probability of mutant epidemic in 
seasonal region #1. Triangles:  non-seasonal region. Pluses: seasonal 
region #2. Crosses: all regions. Each point is the result of 10000 
independent trials. Initially all hosts susceptible except for 10 
individuals with wildtype infections in seasonal region #1. Parameter 
values as in Table S1, except  = 0.1. No mutation.  
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Fig. 4: Probabilities that mutant strains emerging spontaneously from 
existing strains cause epidemics. a, b: Depending on the strength of 
coupling between seasonal and non-seasonal regions when each 
difference between antigenic genotype sections translates into a re-
infection probability of  = 0.1. c, d: Depending on the re-infection 
probability () conferred by each difference between antigenic 
genotype sections when the coupling between seasonal and non-
seasonal regions is intermediate YS = 0.0005. a, c. Mutant strains 
emerging in seasonal region #1. b, d. Mutant strains emerging in non-
seasonal region. All panels show the probability that the mutant 
causes at least 50 simultaneous infections in: circles - seasonal region 
#1, triangles – non-seasonal region, pluses – seasonal region #2. 
Each point is the result of 100 independent trials. Initially all hosts 
susceptible except for 10 individuals with wildtype infections in 
seasonal region #1. Parameter values as in Table S1. 
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Figure S1: Wildtype epidemics. Number of infected individuals over a four year period following 
the introduction of the wildtype strain into a naive population. There is no mutation. Pale lines 
represent 100 independent realisations of the model. Dark lines are the means of these realisations 
after removing any trial for which the epidemic did not persist for at least 6 months.  Blue: 
number of infectious individuals in seasonal region #1. Green: non-seasonal region. Red: seasonal 
region #2. Initially all populations were naive except 10 infected individuals in seasonal region #1. 
Parameter values as in Table S1. Seasonal epidemics peak toward the end of the transmission 
period, show high variability in magnitude and little overlap between regions. Non-seasonal 
epidemics build and decline slowly, show variability in timing but not magnitude, and peak after 
an average of just under two years.  
 
 
 
Figure S2: Probabilities, as a function of introduction time, that at least 50 simultaneous 
infections result from the introduction of a single infected individual. Left panel:  Individual 
infected with wildtype strain introduced into a naive population. Triangles: non-seasonal 
transmission. Circles: seasonal transmission. Centre and right panels: Individual infected with 
mutant strain introduced into a population experiencing a wildtype epidemic resulting from 10 
infected individuals at time 0. Centre panel: non-seasonal region. Right panel: seasonal region. 
The antigenic advantage of the mutant ranges from the capacity to re-infect none of the 
individuals immune to the wildtype ( = 0, black line) to the capacity to re-infect all immune 
individuals ( = 1.0, palest grey line). Each set of points is the result of 10000 independent trials 
with random introduction times. Parameters values as in Table S1. In the non-seasonal region the 
epidemic probability shows a weak response to antigenic advantages of up to 60% re-infection 
but increases significantly above this threshold. The pattern is similar in the seasonal region, but 
less clearly defined because immunity accumulates more slowly.  
 
Figure S3: Epidemiological impact of direct coupling between seasonal regions. Maximum 
number of simultaneous wildtype infections in each of the three years following introduction, as a 
function of the strength of direct coupling between seasonal regions. Top row – no direct 
coupling between seasonal and non-seasonal regions. Middle row – intermediate coupling 
between seasonal and non-seasonal regions. Bottom row – strong coupling between seasonal and 
non-seasonal regions. Blue: maximum number of simultaneous infections in seasonal region #1. 
Green: non-seasonal region. Red: seasonal region #2. The model is composed of all three regions 
and a single virus strain. Each point is the mean of 100 independent realizations after removing 
any trial for which the epidemic did not persist for at least 6 months. Initially all populations were 
naive except 10 infected individuals in seasonal region #1. Parameter values as in Table S1. 
Stronger direct coupling between seasonal regions increases the mean size of epidemics in 
seasonal regions in the first two years unless coupling with the non-seasonal region is strong. 
Direct coupling between seasonal regions has little impact on the epidemiological dynamics in the 
non-seasonal region. Epidemic size may decrease in the third year because immunity has 
accumulated more rapidly. Seasonal region #1 is not affected in the first year because the 
epidemic begins in this region. 
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Figure S4: Epidemiological impact of coupling between seasonal and non-seasonal regions. 
Maximum number of simultaneous wildtype infections in each of the three seasons following 
introduction, as a function of the strength of coupling between non-seasonal and seasonal regions. 
Top row – no direct coupling between seasonal regions. Middle row – intermediate coupling 
between seasonal regions. Bottom row – strong coupling between seasonal regions. Blue: 
maximum number of simultaneous infections in seasonal region #1. Green: non-seasonal region. 
Red: seasonal region #2. Parameters and initial conditions as in Figure S3. Stronger direct 
coupling between seasonal and non-seasonal regions increases the size of all epidemics in the first 
two years. Epidemic size may decrease in the third year because immunity has accumulated more 
rapidly. Seasonal region #1 is not affected in the first year because the epidemic begins in this 
region. 
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Figure S5: Epidemic potential of a single mutant depending on introduction time and antigenic 
advantage. Probability, as a function of introduction time relative to start of wildtype epidemic, a 
single individual infected with a mutant strain leads to a mutant epidemic in each region. Left 
panels: mutant introduced in seasonal region #1. Right panels: mutant introduced in non-seasonal 
region. Top row: mutant has no antigenic advantage. Middle row: mutant has small antigenic 
advantage. Bottom row: mutant has intermediate antigenic advantage. Blue circles: probability of 
mutant epidemic in seasonal region #1. Green triangles: non-seasonal region. Red pluses: 
seasonal region #2. Black crosses: all regions. Each panel is the result of 10000 independent 
model realizations in which the mutant strain is introduced at a random time during the first four 
years of the wildtype epidemic. Initially all populations were naive except 10 individuals infected 
with the wildtype strain in seasonal region #1. Parameter values as Table S1. In the seasonal 
region mutants have a relatively high chance of causing a local epidemic in any year if they are 
introduced in the early part of the transmission season. However, they are unlikely to spread to 
other regions unless they are introduced in the early stages of the wildtype epidemic. In the non­
seasonal region, mutants have a lower, but still significant chance of causing a local epidemic, 
throughout the first year and half of the wildtype epidemic. During the first year of this period, 
mutants also have a significant, but decreasing, probability of spreading to other regions. Small to 
intermediate antigenic advantages have little impact on the epidemic probability of a mutant. 
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Figure S6: Epidemic potential of a single antigenically neutral mutant depending on coupling 
between seasonal and non-seasonal regions. Probability that the random introduction of a single 
individual infected with a mutant strain carrying no antigenic advantage leads to a mutant strain 
epidemic in each region. Left panels: mutant strain introduced to seasonal region #1. Right 
panels: mutant strain introduced to non-seasonal region. Top row: no direct coupling between 
seasonal regions. Middle row: intermediate direct coupling between seasonal regions. Bottom 
row: strong direct coupling between seasonal regions. Blue circles: probability of mutant 
epidemic in seasonal region #1. Green triangles: non-seasonal region. Red pluses: seasonal region 
#2. Black crosses: all regions. An epidemic is defined as at least 50 simultaneous infections. The 
model is composed of all three regions, a wildtype virus strain and a single mutant strain with no 
antigenic advantage relative to the wildtype. Each point is the result of 10000 independent trials 
in which the mutant strain is introduced at a random time during the first four years of the 
wildtype epidemic. Initially all populations were naive except 10 individuals infected with the 
wildtype strain in seasonal region #1. Parameter values as Table S1. Stronger coupling between 
seasonal and non-seasonal regions increases the probability that mutants in seasonal regions will 
spread to other regions. Stronger coupling also initially increases the probability that mutants in 
non-seasonal regions will spread, but the impact saturates for higher coupling. 
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Figure S7: Epidemic potential of a single antigenically neutral mutant depending on coupling 
between seasonal and non-seasonal regions and the year in which it is introduced. Left panel: 
probability that a single individual infected with a mutant strain introduced at a random time in 
the first four years of the wildtype epidemic leads to a mutant epidemic in each region. Centre left 
panel: epidemic probability if the mutant strain is introduced in year 1. Centre right and right 
panels: epidemic probability if the mutant is introduced in year 2, or year 3, expressed as the 
percentage change relative to year 1. Top row: mutant strain introduced to seasonal region #1. 
Bottom row: mutant strain introduced to non-seasonal region. Blue circles: probability of mutant 
epidemic in seasonal region #1. Green triangles: non-seasonal region. Red pluses: seasonal region 
#2. Black crosses: all regions. Each point is the result of 10000 independent trials in which the 
mutant strain is introduced at a random time during the first four years of the wildtype epidemic. 
Initial conditions and parameter values as in Figure S6. Stronger coupling between seasonal and 
non-seasonal regions increases the probability that mutants in seasonal regions will spread to 
other regions. Stronger coupling also initially increases the probability that mutants in non­
seasonal regions will spread, but the impact saturates for higher coupling. Stronger coupling has 
a similar impact on mutants in the second year, but the epidemic probability is considerably lower 
for mutants introduced in the second year, and almost zero in the third year. 
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Figure S8: Epidemic potential of a single mutant with a small antigenic advantage relative to the 
wildtype strain depending on coupling between seasonal and non-seasonal regions and the year in 
which it is introduced. Left panel: probability that a single individual infected with a mutant strain 
introduced at a random time in the first four years of the wildtype epidemic leads to a mutant 
epidemic in each region. Centre left panel: epidemic probability if the mutant strain is introduced 
in year 1. Centre right and right panels: epidemic probability if the mutant is introduced in year 2, 
or year 3, expressed as the percentage change relative to year 1. Top row: mutant strain 
introduced to seasonal region #1. Bottom row: mutant strain introduced to non-seasonal region. 
Blue circles: probability of mutant epidemic in seasonal region #1. Green triangles: non-seasonal 
region. Red pluses: seasonal region #2. Black crosses: all regions. Each point is the result of 
10000 independent trials in which the mutant strain is introduced at a random time during the first 
four years of the wildtype epidemic. Initial conditions and parameter values as in Figure S6. For a 
mutant with a weak antigenic advantage, the relationship between the epidemic probability and 
the strength of coupling is very similar to that for a neutral mutant shown in Figure S7. 
24 
Figure S9: Epidemic potential of a single mutant with an intermediate antigenic advantage 
relative to the wildtype strain depending on coupling between seasonal and non-seasonal regions 
and the year in which it is introduced. Left panel: probability that a single individual infected with 
a mutant strain introduced at a random time in the first four years of the wildtype epidemic leads 
to a mutant epidemic in each region. Centre left panel: epidemic probability if the mutant strain is 
introduced in year 1. Centre right and right panels: epidemic probability if the mutant is 
introduced in year 2, or year 3, expressed as the percentage change relative to year 1. Top row: 
mutant strain introduced to seasonal region #1. Bottom row: mutant strain introduced to non­
seasonal region. Blue circles: probability of mutant epidemic in seasonal region #1. Green 
triangles: non-seasonal region. Red pluses: seasonal region #2. Black crosses: all regions. Each 
point is the result of 10000 independent trials in which the mutant strain is introduced at a random 
time during the first four years of the wildtype epidemic. Initial conditions and parameter values 
as in Figure S6. For a mutant with an intermediate antigenic advantage, the relationship between 
the epidemic probability and the strength of coupling is very similar to that for a neutral mutant 
shown in Figure S7. 
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Figure S10: Epidemic potential of a single mutant depending on year of introduction and 
antigenic advantage. Left panel: Probability, depending on antigenic advantage of mutant relative 
to wildtype strain, that a single individual infected with a mutant strain introduced at a random 
time in the first four years of the wildtype epidemic leads to a mutant epidemic in each region. 
Centre left panel: epidemic probability if the mutant strain is introduced in year 1. Centre right 
and right panels: epidemic probability if the mutant is introduced in year 2, or year 3, expressed 
as the percentage change relative to year 1. Top row: mutant strain introduced to seasonal region 
#1. Bottom row: mutant strain introduced to non-seasonal region. Blue circles: probability of 
mutant epidemic in seasonal region #1. Green triangles: non-seasonal region. Red pluses: 
seasonal region #2. Black crosses: all regions. Each point is the result of 10000 independent trials 
in which the mutant strain is introduced at a random time during the first four years of the 
wildtype epidemic. Initial conditions and parameter values as in Figure S6. Mutants with a greater 
antigenic advantage are more likely to lead to local epidemics, and spread to other regions. 
However, the epidemic probability only begins to increase significantly when the antigenic 
advantage exceeds 0.5. The impact of the antigenic advantage is most pronounced in the non­
seasonal region, in the second and third years, when immunity has accumulated due to the 
wildtype epidemic. 
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Figure S11: Epidemic potential of spontaneous mutants depending on coupling between seasonal 
and non-seasonal regions and the advantage conferred by each antigenic mutation. Probability 
that a novel strain emerging by spontaneous mutation of an existing strain causes an epidemic in 
each region as a function of the strength of coupling between seasonal and non-seasonal regions. 
Left panels: mutants that emerge in seasonal region #1. Right panels: mutants that emerge in non­
seasonal region. Top row: all mutations are antigenically neutral. Middle row: each antigenic 
mutation confers a small advantage (0.1 re-infection probability for each difference between 
antigenic genotype sections). Bottom row: each antigenic mutation confers an intermediate 
advantage (0.3 re-infection probability for each difference between antigenic genotype sections). 
Blue circles: probability of mutant epidemic in seasonal region #1. Green triangles: non-seasonal 
region. Red pluses: seasonal region #2. An epidemic is defined as at least 50 simultaneous 
infections. The model is composed of all three regions, a wildtype virus strain and any number of 
mutant strains emerging from the wildtype strain, or other mutants. Each point is the result of 100 
independent realizations of the model. Initially all populations were naive except 10 individuals 
infected with the wildtype strain in seasonal region #1. Parameter values as Table S1. Stronger 
coupling between seasonal and non-seasonal regions leads to a small increase in the probability 
that spontaneous mutants in seasonal regions will spread to other regions. Stronger coupling also 
leads to consistently increasing probabilities that spontaneous mutants in non-seasonal regions 
will spread to other regions. 
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Figure S12: Epidemic potential of spontaneous mutants depending on direct coupling between 
seasonal regions and advantage of each antigenic mutation. Probability that a novel strain 
emerging by spontaneous mutation of an existing strain causes an epidemic in each region as a 
function of the strength of direct coupling between seasonal regions. Left panels: mutants that 
emerge in seasonal region #1. Right panels: mutants that emerge in non-seasonal region. Top 
row: all mutations are antigenically neutral. Middle row: each antigenic mutation confers a small 
advantage (0.1 re-infection probability for each difference between antigenic genotype sections). 
Bottom row: each antigenic mutation confers an intermediate advantage (0.3 re-infection 
probability for each difference between antigenic genotype sections). Blue circles: probability of 
mutant epidemic in seasonal region #1. Green triangles: non-seasonal region. Red pluses: 
seasonal region #2. Each point is the result of 100 independent realizations. Initial conditions and 
parameter values as in Figure S11. Stronger direct coupling between seasonal regions has little 
impact on the probability that spontaneous mutants cause local or global epidemics. 
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Figure S13: Epidemic potential of spontaneous mutants depending on amplitude of seasonal 
variation in transmission intensity and advantage of each antigenic mutation. Probability that a 
novel strain emerging by spontaneous mutation of an existing strain causes an epidemic in each 
region as a function of the amplitude of seasonal variation in transmission intensity. Left panels: 
mutants that emerge in seasonal region #1. Right panels: mutants that emerge in non-seasonal 
region. Top row: all mutations are antigenically neutral. Middle row: each antigenic mutation 
confers a small advantage (0.1 re-infection probability for each difference between antigenic 
genotype sections). Bottom row: each antigenic mutation confers an intermediate advantage (0.3 
re-infection probability for each difference between antigenic genotype sections). Blue circles: 
probability of mutant epidemic in seasonal region #1. Green triangles: non-seasonal region. Red 
pluses: seasonal region #2. Each point is the result of 100 independent realizations. Initial 
conditions and parameter values as in Figure S11. When the amplitude is low, seasonal 
transmission intensity is too small for sustained outbreak. As the amplitude becomes larger, 
sustained transmission become possible, and mutants can cause epidemics in the seasonal region. 
There is no clearly defined impact on the epidemic potential of non-seasonal mutants. 
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Figure S14: Epidemic potential of spontaneous mutants depending on transmission intensity the 
in non-seasonal region and the advantage of each antigenic mutation. Probability that a novel 
strain emerging by spontaneous mutation of an existing strain causes an epidemic in each region 
as a function of the transmission intensity in the non-seasonal regions, expressed in terms of the 
basic reproductive number R0 = N/( + ). Left panels: mutants that emerge in seasonal region 
#1. Right panels: mutants that emerge in non-seasonal region. Top row: all mutations are 
antigenically neutral. Middle row: each antigenic mutation confers a small advantage (0.1 re-
infection probability for each difference between antigenic genotype sections). Bottom row: each 
antigenic mutation confers an intermediate advantage (0.3 re-infection probability for each 
difference between antigenic genotype sections). For this intermediate antigenic advantage, 
computation became impractically slow for R0 > 1.3 because of an explosion of diversity in some 
realizations. Blue circles: probability of mutant epidemic in seasonal region #1. Green triangles: 
non-seasonal region. Red pluses: seasonal region #2. Each point is the result of 100 independent 
realizations. Initial conditions and parameter values as in Figure S11. More intense transmission 
in the non-seasonal region increases the probability that mutants arising in that region cause local 
epidemics. It may also increase the probability that they spread to seasonal regions, but the 
pattern is not clear, and may be complicated by the impact the change in non-seasonal 
transmission has on the basic epidemiology of all regions. If each mutation confers a small 
antigenic advantage the trend is similar. If mutation confers an intermediate antigenic advantage, 
the impact of increasing non-seasonal transmission intensity is more pronounced and there is a 
critical transmission threshold at which there is an explosion of diversity.   
sets.  
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Figure S15: Epidemic potential of spontaneous mutants depending on the advantage of antigenic 
mutations. Probability that a novel strain emerging by spontaneous mutation of an existing strain 
causes an epidemic in each region as a function of the antigenic advantage associated with each 
mutation, where the re-infection probability is for each difference between antigenic genotype 
sections. Left panels: mutants that emerge in seasonal region #1. Right panels: mutants that 
emerge in non-seasonal region. Blue circles: probability of mutant epidemic in seasonal region #1. 
Green triangles: non-seasonal region. Red pluses: seasonal region #2. Each point is the result of 
100 independent realizations. Initial conditions and parameter values as in Figure S11. A greater 
antigenic advantage associated with each mutation leads to a small increase in the epidemic 
probability. However, if the antigenic advantage exceeds a certain threshold, in this case around 
0.7 there may be an explosive increase in diversity.  
 
 
 
Figure S16: Distribution of emergence times of all spontaneous mutants, and those spontaneous 
mutants that cause significant outbreaks. Baseline case, all mutations antigenically neutral. 
Circles: distribution of emergence times of spontaneous mutants, expressed as the proportion of 
all the mutants appearing over the first four years of the wildtype epidemic that emerge in the 
given time interval.  Crosses: distribution of emergence times of successful mutants, expressed as 
the proportion of all mutants that cause significant outbreaks appearing over the first four years 
that emerge in the given time interval. Blue: mutants emerging in seasonal region #1. Green: 
mutants emerging in non-seasonal region. The model is composed of all three regions, a wildtype 
strain and any number of mutant strains emerging from the wildtype strain, or other mutants. The 
figure summarizes 100 independent realizations of the model. Initially all populations were naive 
except 10 individuals infected with the wildtype strain in seasonal region #1. Parameter values as  
inTable S1.  In the seasonal region the majority of mutants appear in the second half of the first 
year epidemic. The majority of successful mutants appear in the first year epidemic, notably in 
the first half of this epidemic. In the non-seasonal region the majority of mutants appear after one 
and a half to two years. The majority of successful mutants appear after around one year. 
Figure S17: Distribution of emergence times of all spontaneous mutants, and those spontaneous 
mutants that cause significant outbreaks, depending on coupling between regions. All mutations 
antigenically neutral. Left column: strength of coupling between seasonal and non-seasonal 
regions. Centre column: strength of coupling between seasonal regions. Right column: amplitude 
of fluctuations in seasonal transmission intensity. Circles: distribution of emergence times of 
spontaneous mutants, expressed as the proportion of all the mutants appearing over the first four 
years of the wildtype epidemic that emerge in the given time interval. Crosses: distribution of 
emergence times of successful mutants, expressed as the proportion of all mutants that cause 
significant outbreaks appearing over the first four years that emerge in the given time interval. 
Blue: mutants emerging in seasonal region #1. Green: mutants emerging in non-seasonal region. 
Each panel is based on 100 independent realizations of the model. Initial conditions and 
parameter values as in Figure S15. Stronger coupling between seasonal and non-seasonal regions 
causes a greater proportion of all mutants, and successful mutants, to appear in the second year. 
However, in all years, the successful mutants generally appear before the majority. Stronger 
coupling between seasonal and non-seasonal regions causes the epidemic to peak, and produce 
the majority of mutants, earlier. But the majority of successful mutants still emerge before this 
peak. The strength of direct coupling between seasonal regions has little impact. Higher 
maximum intensity transmission in the seasonal region also accelerates the epidemiology, 
resulting in the majority of non-seasonal mutants appearing earlier, and the majority of seasonal 
mutants appearing in the first year. 
32 
 33
 
 
 
 
 
Figure S18: Distribution of emergence times of all spontaneous mutants, and those spontaneous 
mutants that cause significant outbreaks, depending on seasonal and non-seasonal transmission 
intensity. All mutations antigenically neutral. Left column: non-seasonal transmission intensity, 
expressed in terms of R0 = N/( + ). Right column: advantage conferred by each antigenic 
mutation. Circles: distribution of emergence times of spontaneous mutants, expressed as the 
proportion of all the mutants appearing over the first four years of the wildtype epidemic that 
emerge in the given time interval.  Crosses: distribution of emergence times of successful mutants, 
expressed as the proportion of all mutants that cause significant outbreaks appearing over the first 
four years that emerge in the given time interval. Blue: mutants emerging in seasonal region #1. 
Green: mutants emerging in non-seasonal region. Each panel is based on 100 independent 
realizations of the model. Initial conditions and parameter values as in Figure S15. Higher 
intensity transmission in the non-seasonal region accelerates the epidemiology, resulting in the 
majority of mutants in the non-seasonal region appearing earlier, and mutants in the seasonal 
regions being spread more evenly between the first and second years. Weak to intermediate 
advantages associated with antigenic mutations have little impact. A strong advantage leads to a 
more even distribution of emergence times of mutants in the non-seasonal region and a closely 
corresponding distribution for the emergence times of successful mutants. Mutants that appear 
earlier than the majority are no longer favoured.  
 
Figure S19: Transient diversity of the virus population depending on time since the start of the 
wildtype epidemic. Left: number of distinct genotypes present in seasonal region #1. Right: 
number of distinct genotypes present in non-seasonal region at time t. Palest squares: each 
mutation has no antigenic advantage. Triangles: small antigenic advantage ( = 0.1). Dark circles: 5 
intermediate advantage ( = 0.3). Based on 100 independent realizations of the model. Initial 
conditions and parameter values as in Figure S11. Diversity is highest around the epidemic peaks, 
when new mutants are being rapidly generated. Small or intermediate antigenic advantages 
associated with mutation do not have a significant impact on diversity.  
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Figure S20: Cumulative genetic diversity of the virus population. Top row: total number of distinct 
genotypes detected in each region over the course of an epidemic lasting up to 8 years when new 
strains emerge by spontaneous mutation of existing strains. Bottom row: proportion of these genotypes 
that only differ from the wildtype at one antigenic genotype location. Blue circles – seasonal region #1, 15 
green triangles – non-seasonal region. In all but the final column, pale shades indicate that mutation 
has no antigenic advantage, intermediate shades indicate that mutation has a weak antigenic advantage 
( = 0.1) and dark shades indicate an intermediate advantage ( = 0.3). Each point is the mean of 100 
independent realizations of the model. Initial conditions and parameter values as in Figure S11. The 
strength of coupling between regions has little impact on diversity. Increasing the amplitude of the 20 
variation in seasonal transmission intensity increases diversity in the seasonal region if the effective 
reproductive number is close to 1. Increasing transmission intensity in the non-seasonal region 
increases diversity in the seasonal region, but has little impact on the non-seasonal region. If each 
mutation confers an intermediate antigenic advantage, increasing non-seasonal transmission intensity 
may lead to an explosive increase diversity. For  = 0.3, this explosion occurs when R0 = 1.3 and 25 
made further computation unfeasible. Similarly, for fixed R0, increasing the antigenic advantage 
associated with each mutation has little impact on diversity until a critical threshold is reached, here 
around 0.7, beyond which there is an explosive increase in diversity and further computation becomes 
unfeasible. 
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Detailed Model Description 
 
Epidemiological model 
We use a standard SIR framework (1-5) for multiple co-circulating strains with immune cross-
reaction. We divide the host population into seasonal regions S1 and S2, and a non-seasonal (year-5 
round) region Y. In each region we group hosts according to their current immune state and 
infectious state, as set out below. To incorporate immune cross-reaction we let P be the set of all 
possible antigenically differentiable genotypes. Let A be any subset of P, including P and Ø. Let i 
be a single member of P. We then make the following assumptions: 
 10 
 A host can be infected by at most one strain at a time. This assumption is reasonable 
since infected hosts are likely to have much less contact with the rest of the population. 
They may also have a heightened immune state. The observation of reassortment (6) 
indicates that multiple simultaneous infections do occur but we assume this is sufficiently 
rare to ignore for the purposes of this model.  15 
 Cross-immunity reduces susceptibility. Previous infection with the set of strains A 
reduces the probability that a challenge by strain i is successful by a factor f(A, i). If f(A, 
i) = 0 then protection is perfect and infection is impossible. If f(A, i) = 1 then protection is 
absent. The exact form of f is specified below.   
 The host population in each region is well mixed. Each host has an equal probability of 20 
meeting any other host in the same region. 
 The contact rate β(t) is the expected number of host encounters sufficient for transmission 
per unit time. In year-round regions this is constant, (t) = . In seasonal regions it varies 
throughout the year: (t) =  0(1 + sin(2(t + )) for 0 < t < 0.5 and (t) = 0 for 0.5 < t < 
1. Here  is the offset. For seasonal region #1   = 0. For seasonal region #2  = 0.5, 25 
making the transmission periods exactly out of phase.  
 The contact rate between hosts is scaled by a factor ZW  according to the regions W and Z 
in which they are located. Within all regions the contact rate is unchanged: ZZ = 1. 
Between regions the contact rate is greatly reduced:  ZW  << 1.    
 The birth rate of each individual in the population is  per year. The death rate is also . 30 
So the total population size remains constant. All new births are fully susceptible to all 
virus strains.  
 Infected hosts recover after an average of 1/γ years.   
 
We group the host population into classes according to the set of antigenically differentiable 35 
strains they have previously experienced and the strain with which they are currently infected. Let 
RZA be the set of all hosts in region Z that have previously recovered from infection with all the 
strains in set A. The set RZØ contains hosts that have never been infected. Let IZA,i be the set of all 
hosts that are currently infected with strain i and have previously recovered from infection with 
all the strains in set A. All hosts fall into exactly one of these sets. If the number of hosts in each 40 
set is considered continuous, and there is no mutation, differential equations describing the 
epidemiological dynamics in each region Z = S1, S2, Y are:   
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In order to couple regions these equations are modified. Hosts in region Z are also exposed to a 
small proportion of the infected hosts in the two other regions V, W  Z (7). The equations 
become:  5 
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This deterministic expression of the system can be transformed into a stochastic model with a 
continuous time variable and discrete population variables by expressing it in terms of the 
probability of each possible event (8-9):  10 
  
Event Change Probability 
Host in immune class RZA challenged by host in 
infected class IWX,i  
None ZWβ(t)RZAIZX,i 
Above challenge successful RZA  RZA – 1,  
IZA,i  IZA,i + 1 
f(A,i) 
Host in infected class IZA,i recovers IZA,i  IZA,i – 1  
RZAi  RZAi + 1  
γIZA, i 
Host in immune class RZA dies and replaced by new 
birth 
RZA  RZA – 1 
RZØ  RZØ + 1 
RZA 
Host in infected class IZA,i dies and replaced by new 
birth 
IZA,i  IZA,i – 1 
RZØ  RZØ + 1 
IZA,i 
 
If there are p elements in P then the number of possible subsets A is 2p. We need to keep track of 
all possible immune classes, and the combination of each of these classes with an infection strain. 
So the model requires (p + 1)2p variables. It also requires a set of transition equations for each 15 
variable. This system is enormous even when p is small. However, most of these variables will be 
0 because at least one of the strains in the subset A has not yet existed or the classes RZA and IZA,i 
do exist but have become empty due to further infections or recovery. Classes with 0 members 
have no impact on the model. They need not be considered. Computationally, they can be created 
as needed and destroyed when no longer needed. This greatly reduces the number of active 20 
variables and transitions.   
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Other methods have been used to get round the problems of such a large system. The most 
feasible assumes that multiple simultaneous infections can occur, immunity reduces infectivity 
rather than susceptibility and immunity is polarized. After infection a host either gains complete 
immunity with probability f(A, i) or no immunity with probability 1 – f(A, i) (10-12).  All hosts 
are always susceptible to all strains but not all hosts transmit all strains. Since all host are 5 
susceptible immunity can accumulate more quickly than in models where susceptibility is 
reduced and re-infection is rarer. This process may be thought of as a form of boosting. It is 
powerful because, during a large epidemic, a host may be re-infected multiple times. It will have 
multiple opportunities to gain immunity to all strains cross-reactive with the infecting strain. The 
great advantage of this model framework is the host population can be grouped into just 2p 10 
overlapping classes for each region SZi – susceptible to strain i, and IZi – infected with strain i. An 
alternative is to assume that the immune cross-reaction is the same between all strains (13-14).  
The host population can then be grouped according to whether or not they have been previously 
infected with any strain. Finally, the system can be simplified by assuming that immunity is 
polarized but acts on susceptibility. The size of higher order immune groups (those that have 15 
previously experienced more than two strains) can be approximated in terms of lower order 
groups (15). This approximation has been shown to be reasonably accurate for a four strain 
system but its impact in a system with many strains is not clear.  
 
Evolutionary model 20 
In describing the epidemiological model we defined i to be an antigenically differentiable strain 
and A to be a set of such strains. In order to model mutation and immune interaction an explicit 
representation of each strain i is required. This encoding is achieved using a binary string. The 
string is divided into two sections. Section Ga, of length ma, corresponds to antigenic sites and 
determines the antigenic phenotype. Section Gn, of length mn corresponds to sites that are neutral 25 
with respect to the antigenic phenotype. Only the antigenic section of the genotype has an impact 
on the epidemiological population dynamics. The neutral section is just towed along. Each 
element of the bitstring may be thought of as a locus, with two possible allelic states (5, 16). 
Alternatively each element may be thought of as an amino acid or nucleotide, again abstracted as 
having two possible states (17). Encodings closer to those observed in reality could also be used 30 
(18).  
 
As long as a host is infected with strain i, each element of the bitstring genotype for i switches 
with at a very low rate η per year, creating a new strain j. Note that a host only gains immunity to 
a strain on recovery. In this case the host gains immunity to strain j, not strain i. For each infected 35 
host IA,i the antigenic section of the genotype defines i. The neutral section plays no part in the 
epidemiological dynamics and so does not appear in that system. However, for each class IA,i a list 
of all the neutral genotypes sections currently associated with infections in this class is 
maintained, together with the frequency of each of them. The following events are added to the 
stochastic model:  40 
 
Event Change Probability 
Antigenic mutation in infected host set IZA,i, 
strain i switches to strain j  
IZA,i  IZA,i – 1 
IZA,i  IZA,i + 1 
ηmaIZA,i 
Neutral mutation in infected host set IZA,I No change to compartments, 
frequency of neutral genotype 
sections updated 
ηmnIZA,i 
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Antigenic similarity and cross-immunity  
In order to determine the immune cross-reaction between two strains it is necessary to determine 
the similarity between the antigenic sections of their bitstrings G1 and G2. We use the Hamming 
distance. This measure is defined as the number of bitstring locations in the two strains with 
different values. A Hamming distance of 0 indicates two strains are identical. A Hamming 5 
distance of ma indicates every element is different. The cross-immunity between strains G1 and G2 
is the degree of similarity between antibodies to G1 and antigens of G2, or vice versa. It need not 
be the same as the genotypic similarity. Let the Hamming distance between G1 and G2 be h and 
let the cross-immunity be given by g(h), a monotonic increasing function. There is little empirical 
guidance to help determine this function but its form can have a significant impact on the 10 
evolutionary dynamics of the system. If g is concave or linear, any number of antigenically 
distinguishable strains can coexist and selection for immune escape is weak. If g is convex only a 
limited number of antigenic variants can coexist, and selection for immune escape is strong (4-5). 
In order to avoid creating immune selection simply from this functional form, we use a linear 
form g(h) = min{h, 1}. The parameter  is the antigenic advantage associated with a single 15 
point mutation. We must cut off the function at 1 because cross-immunity greater than 1 would be 
cross-enhancement. This phenomenon has not been observed for influenza.  
 
The function g(h) maps genotypic similarity between two strains to immune cross-reaction. We 
now need to extend the framework to a function f(A, G1) that maps genotypic similarity between 20 
G1 and a whole set of strains A to cross immunity. In this case a host has been previously infected 
by all the strains in A and has antibodies to all of those strains. The function f determines how 
much protection those antibodies afford against a strain with antigenic genotype G1. We combine 
these two concepts by defining h0 to be the minimum Hamming distance between G1 and each 
individual strain in A. We then define f(A, G1)  = g(h0) (2). This formulation assumes that only the 25 
strongest antibody reaction is relevant. An alternative method is to define f(A, G1) to be the 
product of all the individual Hamming distances (19). This formulation assumes that the 
antibodies function cooperatively and have a much more powerful effect in concert.  
 
Parameter values 30 
 
Parameter Meaning Base value 
N Population size of each region 106 
 Recovery rate / year 52 
 Natural death rate / year 1/75 
 Amplitude of fluctuation in seasonal effective reproductive number 0.4 
 Non-seasonal transmission intensity (R0 = /( + )) 1.1N( + ) 
 Advantage associated with each antigenic genotype difference  0 
YS Transmission coupling between seasonal and non-seasonal regions 0.0005 
SS Transmission coupling between seasonal regions 0.0005 
 Mutation rate / element / infected individual / year 0.0004 
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